BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Infographics: Dynamic digital data analysis
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Israel
Rise of obesity
Radiopharmaceuticals
Biosimilars
Aging
IVDs on the rise
Coronavirus
Artificial intelligence
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Monday, January 13, 2025
Home
»
Topics
»
Disease categories and therapies
» Dermatologic
Dermatologic
RSS
OraDisc A approved for aphthous ulcers
Oct. 7, 2004
No Comments
Enbrel approved in E.U. for psoriasis
Oct. 5, 2004
No Comments
Pierre Fabre to commercialize Olux in Europe
Oct. 5, 2004
No Comments
Approval sought for proof-of-concept study for ATL-1101 in psoriasis
Oct. 4, 2004
No Comments
European approval for Raptiva for psoriasis
Sep. 30, 2004
No Comments
Desilux enters phase III program for atopic dermatitis
Sep. 30, 2004
No Comments
Non-approvable letter for oral tazarotene
Sep. 29, 2004
No Comments
RegeneRx files to begin phase II study of TB4 for chronic pressure ulcers
Sep. 28, 2004
No Comments
NF-kappaB Decoy set to enter phase I/II trial in 2005
Sep. 28, 2004
No Comments
Enrollment completed for U.S. phase II Psoraxine study
Sep. 27, 2004
No Comments
Previous
1
2
…
284
285
286
287
288
289
290
291
292
…
425
426
Next
RSS